$LGND

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (6m)

—

Win rate (6m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET

$LGNDSEC Form 4bearish

Zimmermann Martine · LIGAND PHARMACEUTICALS INC · 16d agono track record yet

Sold 1,200 @ $285.00 avg · $342,000 · 2026-09-10

Form 4: Zimmermann Martine sold LGND

Zimmermann Martine (Director at LIGAND PHARMACEUTICALS INC) reported an open-market sale of 1,200 shares of LGND at an average $285.00, roughly $342,000, in a Form 4 filed 2026-09-14.

At post $280.65Now $283.49+1.0% since postedas of Sep 18, 4:30 PM ET

1d-1.3%

3d+1.4%

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$LGNDSEC Form 4bearish

Haas Jason · LIGAND PHARMACEUTICALS INC · 47d agono track record yet

Sold 7,138 @ $292.81 avg · $2,090,062 · 2026-08-12

Form 4: Haas Jason sold LGND

Haas Jason (Director at LIGAND PHARMACEUTICALS INC) reported an open-market sale of 7,138 shares of LGND at an average $292.81, roughly $2,090,062, in a Form 4 filed 2026-08-14.

At post $294.60Now $283.49-3.8% since postedas of Sep 18, 4:30 PM ET

1d—

3d-1.0%

1w-2.8%

1m-3.4%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.